422 related articles for article (PubMed ID: 2648150)
1. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
[TBL] [Abstract][Full Text] [Related]
2. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
4. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
5. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
[TBL] [Abstract][Full Text] [Related]
6. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
7. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation.
Kendig JW; Notter RH; Cox C; Reubens LJ; Davis JM; Maniscalco WM; Sinkin RA; Bartoletti A; Dweck HS; Horgan MJ
N Engl J Med; 1991 Mar; 324(13):865-71. PubMed ID: 2000109
[TBL] [Abstract][Full Text] [Related]
8. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study].
Shinwell ES; Zmora E; Leven D; Berger I; Karplus M
Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835
[TBL] [Abstract][Full Text] [Related]
9. Inositol supplementation in premature infants with respiratory distress syndrome.
Hallman M; Bry K; Hoppu K; Lappi M; Pohjavuori M
N Engl J Med; 1992 May; 326(19):1233-9. PubMed ID: 1560798
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic treatment of very premature infants with human surfactant.
Merritt TA; Hallman M; Bloom BT; Berry C; Benirschke K; Sahn D; Key T; Edwards D; Jarvenpaa AL; Pohjavuori M
N Engl J Med; 1986 Sep; 315(13):785-90. PubMed ID: 3528853
[TBL] [Abstract][Full Text] [Related]
11. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome.
Liechty EA; Donovan E; Purohit D; Gilhooly J; Feldman B; Noguchi A; Denson SE; Sehgal SS; Gross I; Stevens D
Pediatrics; 1991 Jul; 88(1):19-28. PubMed ID: 2057268
[TBL] [Abstract][Full Text] [Related]
12. [Effects of surfactant administration in premature infants with severe respiratory distress syndrome].
Morón A; Luaces J; Esteban JC; Medina D; Sánchez JM; Manzano JL
Med Clin (Barc); 1996 Jun; 107(5):165-8. PubMed ID: 8758674
[TBL] [Abstract][Full Text] [Related]
13. Inhaled nitric oxide for premature infants with severe respiratory failure.
Van Meurs KP; Wright LL; Ehrenkranz RA; Lemons JA; Ball MB; Poole WK; Perritt R; Higgins RD; Oh W; Hudak ML; Laptook AR; Shankaran S; Finer NN; Carlo WA; Kennedy KA; Fridriksson JH; Steinhorn RH; Sokol GM; Konduri GG; Aschner JL; Stoll BJ; D'Angio CT; Stevenson DK;
N Engl J Med; 2005 Jul; 353(1):13-22. PubMed ID: 16000352
[TBL] [Abstract][Full Text] [Related]
14. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome.
Gerstmann DR; Minton SD; Stoddard RA; Meredith KS; Monaco F; Bertrand JM; Battisti O; Langhendries JP; Francois A; Clark RH
Pediatrics; 1996 Dec; 98(6 Pt 1):1044-57. PubMed ID: 8951252
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome.
Shapiro DL; Notter RH; Morin FC; Deluga KS; Golub LM; Sinkin RA; Weiss KI; Cox C
Pediatrics; 1985 Oct; 76(4):593-9. PubMed ID: 3900907
[TBL] [Abstract][Full Text] [Related]
16. Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trials.
Kendig JW; Notter RH; Cox C; Aschner JL; Benn S; Bernstein RM; Hendricks-Munoz K; Maniscalco WM; Metlay LA; Phelps DL
Pediatrics; 1988 Nov; 82(5):756-62. PubMed ID: 3054783
[TBL] [Abstract][Full Text] [Related]
17. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
Laughon M; Bose C; Moya F; Aschner J; Donn SM; Morabito C; Cummings JJ; Segal R; Guardia C; Liu G;
Pediatrics; 2009 Jan; 123(1):89-96. PubMed ID: 19117865
[TBL] [Abstract][Full Text] [Related]
18. Does prophylactic use of bovine surfactant change drug utilization in very premature infants during neonatal period?
Gortner L; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL
Dev Pharmacol Ther; 1991; 16(1):1-6. PubMed ID: 1879246
[TBL] [Abstract][Full Text] [Related]
19. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
Dunn MS; Shennan AT; Zayack D; Possmayer F
Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
